Transcutaneous Oximetry Systems Market

Transcutaneous Oximetry Systems Market Size

The global transcutaneous oximetry systems market size was valued at USD 213.4 million in 2024 and is expected to exhibit growth at a CAGR of 5.4% from 2025 to 2034. The high market growth can be attributed to the growing incidence of peripheral artery disease, technological advancements in non-invasive monitoring, rising geriatric population, and surging need for wound care management, among other contributing factors.

Moreover, the rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is driving the demand for transcutaneous oximetry systems. For instance, according to the World Health Organization (WHO), around 422 million people worldwide have diabetes, with 15% developing diabetic foot ulcers during their lifetime. Additionally, the Centers for Disease Control and Prevention (CDC) reports that pressure ulcers affect 2.5 million patients annually in the U.S. These devices play a crucial role in assessing tissue oxygenation and supporting wound healing strategies, particularly for patients with impaired blood flow.

Furthermore, with a growing emphasis on home-based patient care, the demand for portable and easy-to-use transcutaneous oximetry systems has increased. These devices enable patients to monitor their oxygen levels at home, improving disease management and reducing hospital visits.

Transcutaneous oximetry systems are non-invasive medical devices designed to measure the partial pressure of oxygen (tcpO?) and sometimes carbon dioxide (tcpCO?) in the skin. They use specialized sensors placed on the skin surface to evaluate oxygen delivery and perfusion in tissues, providing critical information for diagnosing and managing conditions such as peripheral vascular disorders, wound healing, and neonatal care.

Transcutaneous Oximetry Systems Market Trends

The market is witnessing significant growth driven by continuous innovations in non-invasive monitoring, surging demand for integrated digital health platforms, and growing home healthcare adoption, among other factors are boosting the industry growth.

• A growing trend in advanced wound care protocols involves the incorporation of transcutaneous oximetry systems. These devices are increasingly used to evaluate wound healing potential, particularly for chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers.
  
• Furthermore, the integration of these systems with digital health solutions, including mobile apps and telemedicine platforms, is emerging as a key trend. This enables healthcare providers to remotely monitor tissue oxygenation levels and deliver timely interventions, supporting the rise of telehealth services and driving market demand.
  

Transcutaneous Oximetry Systems Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on channel type, the market is classified into multichannel and single channel. The multichannel segment generated the highest revenue of USD 156.5 million in 2024.

• Multichannel systems enable the simultaneous measurement of oxygen levels at multiple sites, offering comprehensive insights into tissue oxygenation. This functionality enhances diagnostic accuracy, particularly for patients with complex conditions such as peripheral artery disease or chronic wounds.
  
• Additionally, these systems streamline the diagnostic process by reducing the time required for multiple single-site measurements. This efficiency is especially advantageous in high-volume settings like hospitals and wound care clinics, driving their adoption and contributing to segmental growth in the market.
  

Based on application, the transcutaneous oximetry systems market is classified into peripheral vascular disorders, diabetic foot ulcers, preterm births, and other applications The peripheral vascular disorders segment accounted for USD 81.3 million revenue in 2024 and is anticipated to grow at a CAGR of 5.7% between 2025 to 2034 period.

• The increasing prevalence of peripheral vascular disease (PVD) is driving the demand for transcutaneous oximetry systems. For instance, as per the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people aged 40 and older in the U.S. have PVD. The rise in PVD cases is attributed to several risk factors, making these monitoring systems crucial for measuring oxygen levels in peripheral tissues and supporting the effective detection and management of PVD.
  
• Early diagnosis of PVD is vital to prevent severe complications such as critical limb ischemia and amputations. Transcutaneous oximetry systems offer non-invasive, real-time monitoring of tissue oxygenation, enabling timely detection and intervention for at-risk patients. These advantages are expected to drive growth in this market segment.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the transcutaneous oximetry systems market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 153.8 million by the end of the forecast period.

• Hospitals are increasingly adopting transcutaneous oximetry systems to enhance patient monitoring, particularly for individuals with chronic conditions such as PVD, diabetes, and respiratory disorders. These systems offer continuous, non-invasive measurement of tissue oxygenation, enabling early detection and improving patient outcomes.
  
• Additionally, hospitals, especially those with specialized departments like wound care and vascular surgery are using transcutaneous oximetry systems to assess tissue oxygenation levels. This information guides decisions on wound healing, revascularization procedures, and amputation, leading to better surgical outcomes and reduced post-surgical complications. These factors are expected to drive segmental growth in the market.
  

Looking for region specific data?

Download Free PDF

U.S. transcutaneous oximetry systems market accounted for USD 97 million revenue in 2024 and is anticipated to grow at a CAGR of 4.1% between 2025 to 2034 period.

• The U.S. is a leader in medical technology innovation, with advancements in these systems driving adoption across hospitals and healthcare facilities. Improvements in sensor accuracy, portability, and wireless connectivity make these systems more efficient, user-friendly, and adaptable to various clinical settings.
  
• Further, there is a growing focus on preventive healthcare in the country, which encourages the early detection of vascular and respiratory issues. Transcutaneous oximetry systems play a vital role in this approach by helping healthcare providers monitor tissue oxygenation and prevent the progression of conditions like PVD, diabetes-related complications, and respiratory diseases, contributing to regional growth.
  

Germany transcutaneous oximetry systems market is projected to grow remarkably in the coming years.

• Germany has a robust healthcare system with well-established hospitals and medical institutions that are adopting advanced diagnostic technologies. Transcutaneous oximetry systems are being integrated into routine clinical practice for monitoring patients with vascular and respiratory disorders, driving market growth.
  
• The country’s healthcare policies and reimbursement systems support the adoption of advanced medical devices, including transcutaneous oximetry systems. This regulatory environment promotes the use of these devices in hospitals and clinics by providing financial incentives and ensuring coverage for diagnostic procedures involving these systems.
  

Japan holds a dominant position in the Asia Pacific transcutaneous oximetry systems market.

• Japan's healthcare sector reflects the country's technological advancements, with an increasing adoption of medical devices, including transcutaneous oximetry systems. These systems provide enhanced accuracy, portability, and user-friendly operation, making them integral to both hospital and outpatient care settings. This widespread adoption contributes to market growth.
  
• Moreover, the country is investing heavily in medical research, particularly in vascular health, respiratory care, and chronic disease management. The use of transcutaneous oximetry systems in clinical research is expanding, allowing researchers to monitor tissue oxygenation levels in real time, thereby supporting the broader clinical adoption of these systems.
  

Transcutaneous Oximetry Systems Market Share

The market features competition among several key players. These companies focus on technological innovations and product portfolio expansion. Their investments target advanced, non-invasive oximetry systems that deliver improved accuracy, portability, and user-friendliness. The companies collaborate with healthcare providers to incorporate these systems into routine clinical practices for peripheral vascular disease and respiratory disorders. The market witnesses strategic partnerships, mergers, and acquisitions as companies aim to strengthen their market position and expand their geographical presence.

Transcutaneous Oximetry Systems Market Companies

Prominent players operating in the transcutaneous oximetry systems industry include:

• ADVIN
• Cephalon
• Dräger
• ELCAT
• medicap
• PERIMED
• PHILIPS
• RADIOMETER
• sentec
  

Transcutaneous Oximetry Systems Industry News:

• In May 2022, Radiometer announced a partnership with Etiometry to enhance neonatal intensive care workflows and patient care. By integrating the Etiometry platform with Radiometer’s real-time transcutaneous monitoring solutions, clinicians across the care continuum can now view carbon dioxide trends alongside other physiological parameters, all consolidated on one screen to streamline patient care management. As a result, this collaboration further strengthens Radiometer’s portfolio of transcutaneous oximetry systems.
  

The transcutaneous oximetry systems market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Channel Type

• Multichannel
• Single channel

Market, By Application

• Peripheral vascular disorders
• Diabetic foot ulcers
• Preterm births
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Diagnostic centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE